|
Real-time Estimate
Cboe BZX
15:10:56 10/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 7.665 USD | +0.46% |
|
-11.44% | -2.69% |
| 11-04 | BioCryst Pharmaceuticals, Inc., Q3 2026 Earnings Call, Nov 04, 2026 | |
| 11-04 | Wedbush Adjusts BioCryst Pharmaceuticals PT to $17 From $18, Maintains Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.46% | -11.44% | -9.21% | -22.87% | -2.69% | +5.42% | +52.41% | -40.38% | +49.70% | 1.96B | |
| +0.01% | +8.40% | -4.75% | -2.92% | +65.82% | +58.48% | +69.01% | +18.37% | - | 68.22B | |
| +1.97% | +10.32% | +18.69% | +13.46% | +21.40% | +16.77% | +91.55% | +224.22% | +6,187.57% | 59.82B | |
| -0.21% | +0.98% | +14.74% | +13.63% | +22.46% | +23.33% | +96.83% | -9.76% | +263.27% | 56.07B | |
| +0.86% | +17.99% | +19.54% | +16.67% | +37.87% | +27.24% | +110.37% | +13.82% | +1,066.09% | 47.67B | |
| -1.08% | +5.20% | +5.35% | +14.15% | +22.55% | +29.66% | +40.95% | +9.57% | +252.62% | 45.95B | |
| -1.47% | +1.31% | +1.45% | -4.93% | +147.04% | +213.68% | +898.33% | +520.73% | - | 43.29B | |
| -3.33% | +5.73% | +13.03% | +1.86% | +17.76% | +23.28% | +47.32% | +20.15% | +183.22% | 35.66B | |
| -0.08% | -2.15% | +46.32% | +82.68% | +79.53% | +94.03% | +69.02% | +30.95% | +200.50% | 34.73B | |
| +1.95% | +12.36% | +19.06% | -12.91% | -32.57% | -38.85% | +394.11% | +272.54% | +725.83% | 25.47B | |
| +1.43% | +15.23% | -5.75% | +7.59% | +57.82% | +45.26% | +1.58% | -52.29% | - | 25.6B | |
| +0.43% | +0.29% | -9.04% | -6.06% | -8.43% | -17.03% | -12.44% | -62.97% | - | 21.7B | |
| -0.95% | +0.09% | +7.10% | +10.23% | +18.24% | +10.60% | +141.17% | +203.23% | +1,827.66% | 18.82B | |
| -1.25% | -1.99% | +18.47% | +33.82% | +61.69% | +71.14% | +237.48% | +286.42% | +350.25% | 17.51B | |
| +0.53% | +0.50% | +12.90% | +25.19% | +40.51% | +51.17% | +76.53% | -13.31% | +116.25% | 16.69B | |
| -0.31% | +2.64% | +13.12% | +0.45% | - | - | - | - | - | 17.07B | |
| -1.28% | -2.04% | +14.19% | +24.43% | +72.79% | +103.99% | +100.41% | -11.07% | +357.32% | 16.93B | |
| -6.57% | +7.56% | +7.11% | +3.23% | +202.10% | +183.41% | +320.74% | +1,489.99% | +849.20% | 17.29B | |
| -2.88% | +0.10% | +24.07% | +22.84% | +11.94% | +29.36% | -20.43% | -25.41% | +148.02% | 15.55B | |
| -2.84% | +6.63% | +22.02% | +50.67% | +40.49% | +15.58% | - | - | - | 15.4B | |
| Average | -0.73% | +3.69% | +11.42% | +13.56% | +46.12% | +49.82% | +150.83% | +159.71% | +898.39% | 30B | |
| Weighted average by Cap. | -0.42% | +4.83% | +11.69% | +13.38% | +47.46% | +51.42% | +159.35% | +136.24% | +1,328.65% |
- Stock Market
- Stocks
- BCRX Stock
- Sector BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
